{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T21:09:54Z","timestamp":1789420194586,"version":"build-2803163510"},"reference-count":124,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["NRF-2019R1A2C2085739 NRF-2020R1A4A2002894"],"award-info":[{"award-number":["NRF-2019R1A2C2085739 NRF-2020R1A4A2002894"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Mol. Biosci."],"abstract":"<jats:p>The inflammasome is a molecular platform that is created in the cytosolic compartment to mediate the host immunological response to cellular injury and infection. Caspase-1 may be activated by the inflammasome, which leads to the generation of the inflammatory cytokines interleukin-1\u03b2 (IL-1\u03b2) and IL-18 and the beginning of pyroptosis, which is a type of proinflammatory cell death. Scientists have identified a number of different inflammasomes in the last 2 decades. The NLRP3 inflammasome has been studied the most, and its activity may be triggered by a broad range of different inducers. However, activation of the NLRP3 inflammasome in a manner that is not properly controlled is also a factor in the etiology of many human illnesses. Accumulating evidence indicates that the NLRP3 inflammasome plays a significant role in the innate and adaptive immune systems and the development of various arthritic illnesses, such as rheumatoid arthritis, ankylosing spondylitis, and gout. The present review provides a concise summary of the biological properties of the NLRP3 inflammasome and presents the fundamental processes behind its activation and control. We discuss the role of the inflammasome in the pathogenesis of arthritic diseases, such as rheumatoid arthritis, ankylosing spondylitis, and gout, and the potential of newly developed therapies that specifically target the inflammasome or its products for the treatment of inflammatory diseases, with a particular emphasis on treatment and clinical application.<\/jats:p>","DOI":"10.3389\/fmolb.2022.1027917","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T06:05:26Z","timestamp":1666937126000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Inflammasomes and their roles in arthritic disease pathogenesis"],"prefix":"10.3389","volume":"9","author":[{"given":"Gabsik","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han Chang","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Yeon","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Suk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,28]]},"reference":[{"key":"B1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00011-017-1119-2","article-title":"Polymorphisms and expression of inflammasome genes are associated with the development and severity of rheumatoid arthritis in Brazilian patients","volume":"67","author":"Addobbati","year":"2018","journal-title":"Inflamm. Res."},{"key":"B2","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11926-008-0060-3","article-title":"Are spondyloarthropathies as common as rheumatoid arthritis worldwide? A review","volume":"10","author":"Akkoc","year":"2008","journal-title":"Curr. Rheumatol. Rep."},{"key":"B3","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1007\/s00281-019-00753-4","article-title":"Omnipresence of inflammasome activities in inflammatory bone diseases","volume":"41","author":"Alippe","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"6630","DOI":"10.1038\/s41598-017-07014-0","article-title":"Bone matrix components activate the NLRP3 inflammasome and promote osteoclast differentiation","volume":"7","author":"Alippe","year":"2017","journal-title":"Sci. Rep."},{"key":"B5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2474-12-153","article-title":"Efficacy and safety of the human anti-IL-1\u03b2 monoclonal antibody canakinumab in rheumatoid arthritis: results of a 12-week, phase II, dose-finding study","volume":"12","author":"Alten","year":"2011","journal-title":"BMC Musculoskelet. Disord."},{"key":"B6","doi-asserted-by":"publisher","first-page":"12515","DOI":"10.1096\/fj.201802805RR","article-title":"Activation of ROS\/MAPKs\/NF-\u03baB\/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis","volume":"33","author":"An","year":"2019","journal-title":"Faseb J."},{"key":"B7","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.autrev.2009.06.002","article-title":"Peptidylarginine deiminase 4 and citrullination in health and disease","volume":"9","author":"Anzilotti","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"B8","doi-asserted-by":"publisher","first-page":"E905","DOI":"10.3390\/ijms18050905","article-title":"Matrix metalloproteinase gene activation resulting from disordred epigenetic mechanisms in rheumatoid arthritis","volume":"18","author":"Araki","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"B9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1186\/s13075-015-0902-0","article-title":"Soluble biglycan: A potential mediator of cartilage degradation in osteoarthritis","volume":"17","author":"Barreto","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"B10","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.4049\/jimmunol.1201516","article-title":"NLRP3 inflammasome activity is negatively controlled by miR-223","volume":"189","author":"Bauernfeind","year":"2012","journal-title":"J. Immunol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"254","DOI":"10.3389\/fimmu.2017.00254","article-title":"Cellular and molecular dynamics of Th17 differentiation and its developmental plasticity in the intestinal immune response","volume":"8","author":"Bhaumik","year":"2017","journal-title":"Front. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1002\/1529-0131(200104)44:4<761:AID-ANR132>3.0.CO;2-S","article-title":"The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis","volume":"44","author":"Bl\u00e4ss","year":"2001","journal-title":"Arthritis Rheum."},{"key":"B13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: Mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat. Rev. Immunol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1189\/jlb.1A1215-543R","article-title":"IL-1\u03b2 differently stimulates proliferation and multinucleation of distinct mouse bone marrow osteoclast precursor subsets","volume":"100","author":"Cao","year":"2016","journal-title":"J. Leukoc. Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"598263","DOI":"10.3389\/fcell.2020.598263","article-title":"Communications between bone marrow macrophages and bone cells in bone Remodeling","volume":"8","author":"Chen","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1002\/art.40807","article-title":"Contemporary prevalence of gout and Hyperuricemia in the United States and decadal Trends: The national health and Nutrition Examination Survey, 2007-2016","volume":"71","author":"Chen-Xu","year":"2019","journal-title":"Arthritis Rheumatol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.3892\/etm.2021.10544","article-title":"NLRP3 gene polymorphisms and expression in rheumatoid arthritis","volume":"22","author":"Cheng","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"B18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13075-015-0775-2","article-title":"Enhanced activity of NLRP3 inflammasome in peripheral blood cells of patients with active rheumatoid arthritis","volume":"17","author":"Choulaki","year":"2015","journal-title":"Arthritis Res. Ther."},{"key":"B19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"key":"B20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.2174\/138161207780163006","article-title":"Inflammatory caspases: Targets for novel therapies","volume":"13","author":"Cornelis","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1186\/ar4174","article-title":"Use of NSAIDs in treating patients with arthritis","volume":"15","author":"Crofford","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"B22","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1002\/art.30155","article-title":"The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases","volume":"63","author":"Crowson","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B23","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41584-020-0441-1","article-title":"Global epidemiology of gout: Prevalence, incidence, treatment patterns and risk factors","volume":"16","author":"Dehlin","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/eji.201141550","article-title":"A clinical perspective of IL-1\u03b2 as the gatekeeper of inflammation","volume":"41","author":"Dinarello","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1749-6632.1998.tb08307.x","article-title":"Interleukin-1 beta, interleukin-18, and the interleukin-1 beta converting enzyme","volume":"856","author":"Dinarello","year":"1998","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1111\/jcmm.12353","article-title":"Decreased expression of microRNA-21 correlates with the imbalance of Th17 and Treg cells in patients with rheumatoid arthritis","volume":"18","author":"Dong","year":"2014","journal-title":"J. Cell. Mol. Med."},{"key":"B27","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1016\/S0140-6736(11)60071-8","article-title":"Spondyloarthritis","volume":"377","author":"Dougados","year":"2011","journal-title":"Lancet"},{"key":"B28","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.4049\/jimmunol.1000105","article-title":"Inflammasome activation by adenylate cyclase toxin directs Th17 responses and protection against Bordetella pertussis","volume":"185","author":"Dunne","year":"2010","journal-title":"J. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"B30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1369\/0022155417740880","article-title":"Danger-associated molecular patterns derived from the extracellular matrix provide Temporal control of innate immunity","volume":"66","author":"Frevert","year":"2018","journal-title":"J. Histochem. Cytochem."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1007\/s10787-020-00757-9","article-title":"Current and novel therapeutic targets in the treatment of rheumatoid arthritis","volume":"28","author":"George","year":"2020","journal-title":"Inflammopharmacology"},{"key":"B32","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1002\/art.41644","article-title":"Inflammasome activation in ankylosing spondylitis is associated with gut dysbiosis","volume":"73","author":"Guggino","year":"2021","journal-title":"Arthritis Rheumatol."},{"key":"B33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1186\/s13075-018-1740-7","article-title":"Downregulation of miRNA17-92 cluster marks V\u03b39V\u03b42 T cells from patients with rheumatoid arthritis","volume":"20","author":"Guggino","year":"2018","journal-title":"Arthritis Res. Ther."},{"key":"B34","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1038\/icb.2011.112","article-title":"The interplay between endoplasmic reticulum stress and inflammation","volume":"90","author":"Hasnain","year":"2012","journal-title":"Immunol. Cell Biol."},{"key":"B35","doi-asserted-by":"publisher","first-page":"2550","DOI":"10.1038\/s41467-018-04947-6","article-title":"Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity","volume":"9","author":"He","year":"2018","journal-title":"Nat. Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends biochem. Sci."},{"key":"B37","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1038\/cmi.2012.10","article-title":"Regulation of TH17 cell differentiation by innate immune signals","volume":"9","author":"Huang","year":"2012","journal-title":"Cell. Mol. Immunol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s11845-017-1634-8","article-title":"miR-210 expression in PBMCs from patients with systemic lupus erythematosus and rheumatoid arthritis","volume":"187","author":"Huang","year":"2018","journal-title":"Ir. J. Med. Sci."},{"key":"B40","doi-asserted-by":"publisher","first-page":"e8689","DOI":"10.15252\/emmm.201708689","article-title":"Tranilast directly targets NLRP3 to treat inflammasome-driven diseases","volume":"10","author":"Huang","year":"2018","journal-title":"EMBO Mol. Med."},{"key":"B41","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1016\/j.bbagen.2014.07.012","article-title":"Suppression of the pro-inflammatory NLRP3\/interleukin-1\u03b2 pathway in macrophages by the thioredoxin reductase inhibitor auranofin","volume":"1840","author":"Isakov","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"B42","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1136\/annrheumdis-2014-205326","article-title":"Downregulation of miR-193b in systemic sclerosis regulates the proliferative vasculopathy by urokinase-type plasminogen activator expression","volume":"75","author":"Iwamoto","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu. Rev. Immunol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1016\/j.ebiom.2019.09.010","article-title":"Dual function of miR-1248 links interferon induction and calcium signaling defects in Sj\u00f6gren's syndrome","volume":"48","author":"Jang","year":"2019","journal-title":"EBioMedicine"},{"key":"B45","first-page":"A70","article-title":"P160 the first phase 2A proof-of-concept study of a selective NLRP3 inflammasome inhibitor, dapansutrile\u2122 (OLT1177\u2122), in acute gout","volume":"78","author":"Jansen","year":"2019","journal-title":"Ann. Rheumatic Dis."},{"key":"B46","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1084\/jem.20171419","article-title":"Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders","volume":"214","author":"Jiang","year":"2017","journal-title":"J. Exp. Med."},{"key":"B47","doi-asserted-by":"publisher","first-page":"752546","DOI":"10.3389\/fendo.2021.752546","article-title":"NLRP3 inflammasome: A new target for prevention and control of osteoporosis?","volume":"12","author":"Jiang","year":"2021","journal-title":"Front. Endocrinol."},{"key":"B48","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41419-021-03562-6","article-title":"Protectin DX restores Treg\/T(h)17 cell balance in rheumatoid arthritis by inhibiting NLRP3 inflammasome via miR-20a","volume":"12","author":"Jin","year":"2021","journal-title":"Cell Death Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1056\/NEJMoa061592","article-title":"NALP1 in vitiligo-associated multiple autoimmune disease","volume":"356","author":"Jin","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"B50","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.immuni.2007.10.002","article-title":"Intracellular NOD-like receptors in host defense and disease","volume":"27","author":"Kanneganti","year":"2007","journal-title":"Immunity"},{"key":"B51","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1038\/s41598-017-00139-2","article-title":"The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"key":"B52","first-page":"630","article-title":"Differential expressions of NOD-like receptors and their associations with inflammatory responses in rheumatoid arthritis","volume":"35","author":"Kim","year":"2017","journal-title":"Clin. Exp. Rheumatol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3343\/alm.2022.42.2.293","article-title":"Clinical significance of elevated serum caspase-1 levels in patients with ankylosing spondylitis","volume":"42","author":"Kim","year":"2022","journal-title":"Ann. Lab. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.cca.2018.08.022","article-title":"NLRP3 inflammasomes and NLRP3 inflammasome-derived proinflammatory cytokines in peripheral blood mononuclear cells of patients with ankylosing spondylitis","volume":"486","author":"Kim","year":"2018","journal-title":"Clin. Chim. Acta."},{"key":"B55","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.bbrc.2019.02.141","article-title":"TXNIP-mediated nuclear factor-\u03baB signaling pathway and intracellular shifting of TXNIP in uric acid-induced NLRP3 inflammasome","volume":"511","author":"Kim","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B56","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/s2665-9913(20)30065-5","article-title":"Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: An open-label, dose-adaptive, proof-of-concept, phase 2a trial","volume":"2","author":"Kl\u00fcck","year":"2020","journal-title":"Lancet Rheumatol."},{"key":"B57","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","article-title":"Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions","volume":"18","author":"Komatsu","year":"2022","journal-title":"Nat. Rev. Rheumatol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.cell.2014.04.007","article-title":"Mechanisms and functions of inflammasomes","volume":"157","author":"Lamkanfi","year":"2014","journal-title":"Cell"},{"key":"B59","doi-asserted-by":"publisher","first-page":"38622","DOI":"10.1038\/srep38622","article-title":"Targeting ASC in NLRP3 inflammasome by caffeic acid phenethyl ester: A novel strategy to treat acute gout","volume":"6","author":"Lee","year":"2016","journal-title":"Sci. Rep."},{"key":"B60","doi-asserted-by":"publisher","first-page":"E2138","DOI":"10.3390\/molecules24112138","article-title":"Epigallocatechin-3-Gallate prevents acute gout by suppressing NLRP3 inflammasome activation and mitochondrial DNA synthesis","volume":"24","author":"Lee","year":"2019","journal-title":"Molecules"},{"key":"B61","doi-asserted-by":"publisher","first-page":"95","DOI":"10.4110\/in.2011.11.2.95","article-title":"Role of innate immunity in diabetes and metabolism: recent progress in the study of inflammasomes","volume":"11","author":"Lee","year":"2011","journal-title":"Immune Netw."},{"key":"B62","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1073\/pnas.1222808110","article-title":"NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1\u03b2 processing via the NLRP1 inflammasome","volume":"110","author":"Levandowski","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.3389\/fimmu.2019.01408","article-title":"Immune function and diversity of osteoclasts in Normal and pathological conditions","volume":"10","author":"Madel","year":"2019","journal-title":"Front. Immunol."},{"key":"B64","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nrrheum.2009.258","article-title":"Disease modification in ankylosing spondylitis","volume":"6","author":"Maksymowych","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1002\/art.34442","article-title":"Motion for debate: The development of ankylosis in ankylosing spondylitis is largely dependent on inflammation","volume":"64","author":"Maksymowych","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B66","doi-asserted-by":"publisher","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","article-title":"OLT1177, a \u03b2-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation","volume":"115","author":"Marchetti","year":"","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B67","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13075-018-1664-2","article-title":"NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis","volume":"20","author":"Marchetti","year":"","journal-title":"Arthritis Res. Ther."},{"key":"B68","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1136\/annrheumdis-2013-203276","article-title":"Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment","volume":"73","author":"Mathews","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"B70","doi-asserted-by":"publisher","first-page":"Cd005468","DOI":"10.1002\/14651858.CD005468.pub2","article-title":"TNF-alpha inhibitors for ankylosing spondylitis","volume":"4","author":"Maxwell","year":"2015","journal-title":"Cochrane Database Syst. Rev."},{"key":"B71","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"B72","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1016\/j.immuni.2009.04.012","article-title":"A mutation in the Nlrp3 gene causing inflammasome hyperactivation potentiates Th17 cell-dominant immune responses","volume":"30","author":"Meng","year":"2009","journal-title":"Immunity"},{"key":"B73","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.3899\/jrheum.090074","article-title":"Anakinra for rheumatoid arthritis: A systematic review","volume":"36","author":"Mertens","year":"2009","journal-title":"J. Rheumatol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"795","DOI":"10.4049\/jimmunol.1800720","article-title":"Cutting Edge: Protein arginine deiminase 2 and 4 regulate NLRP3 inflammasome-dependent IL-1\u03b2 maturation and ASC speck formation in macrophages","volume":"203","author":"Mishra","year":"2019","journal-title":"J. Immunol."},{"key":"B75","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1038\/nature06664","article-title":"The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response","volume":"452","author":"Muruve","year":"2008","journal-title":"Nature"},{"key":"B76","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/cr.2010.159","article-title":"Role of NF-\u03baB in the skeleton","volume":"21","author":"Novack","year":"2011","journal-title":"Cell Res."},{"key":"B77","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1152\/physrev.00036.2016","article-title":"Osteoimmunology: The Conceptual Framework Unifying the immune and skeletal systems","volume":"97","author":"Okamoto","year":"2017","journal-title":"Physiol. Rev."},{"key":"B78","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrrheum.2015.95","article-title":"Cartilage damage in osteoarthritis and rheumatoid arthritis--two unequal siblings","volume":"11","author":"Pap","year":"2015","journal-title":"Nat. Rev. Rheumatol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"583","DOI":"10.3109\/08916930903540432","article-title":"Two SNPs in NLRP3 gene are involved in the predisposition to type-1 diabetes and celiac disease in a pediatric population from northeast Brazil","volume":"43","author":"Pontillo","year":"2010","journal-title":"Autoimmunity"},{"key":"B80","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.autrev.2016.06.001","article-title":"Detection of novel diagnostic antibodies in ankylosing spondylitis: An overview","volume":"15","author":"Quaden","year":"2016","journal-title":"Autoimmun. Rev."},{"key":"B81","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/14740338.2018.1486819","article-title":"Anakinra for the treatment of rheumatoid arthritis: A safety evaluation","volume":"17","author":"Ram\u00edrez","year":"2018","journal-title":"Expert Opin. Drug Saf."},{"key":"B82","doi-asserted-by":"publisher","first-page":"E2157","DOI":"10.3390\/cells9102157","article-title":"Multitasking by the OC lineage during bone infection: Bone resorption, immune modulation, and microbial Niche","volume":"9","author":"Roper","year":"2020","journal-title":"Cells"},{"key":"B83","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/cei.12667","article-title":"Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1\u03b2 via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: A possible implication for therapeutic decision in these patients","volume":"182","author":"Ruscitti","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1136\/annrheumdis-2019-215920","article-title":"Global, regional and national burden of rheumatoid arthritis 1990-2017: A systematic analysis of the Global Burden of disease study 2017","volume":"78","author":"Safiri","year":"2019","journal-title":"Ann. Rheum. Dis."},{"key":"B85","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1084\/jem.20061775","article-title":"Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction","volume":"203","author":"Sato","year":"2006","journal-title":"J. Exp. Med."},{"key":"B86","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1126\/science.1184003","article-title":"The NLRP3 inflammasome: A sensor for metabolic danger?","volume":"327","author":"Schroder","year":"2010","journal-title":"Science"},{"key":"B87","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1021\/acs.jmedchem.0c01307","article-title":"Strategies for targeting the NLRP3 inflammasome in the clinical and Preclinical space","volume":"64","author":"Schwaid","year":"2021","journal-title":"J. Med. Chem."},{"key":"B88","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1007\/s004280000282","article-title":"Continuous recruitment, co-expression of tumour necrosis factor-alpha and matrix metalloproteinases, and apoptosis of macrophages in gout tophi","volume":"437","author":"Schweyer","year":"2000","journal-title":"Virchows Arch."},{"key":"B89","doi-asserted-by":"publisher","first-page":"12299","DOI":"10.1038\/s41598-019-48770-5","article-title":"Association of MTMR3 rs12537 at miR-181a binding site with rheumatoid arthritis and systemic lupus erythematosus risk in Egyptian patients","volume":"9","author":"Senousy","year":"2019","journal-title":"Sci. Rep."},{"key":"B90","doi-asserted-by":"publisher","first-page":"618231","DOI":"10.3389\/fimmu.2020.618231","article-title":"Regulation of the NLRP3 inflammasome by post-Translational Modifications and small molecules","volume":"11","author":"Seok","year":"2020","journal-title":"Front. Immunol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s12272-021-01307-9","article-title":"Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases","volume":"44","author":"Seok","year":"2021","journal-title":"Arch. Pharm. Res."},{"key":"B92","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nature01991","article-title":"Molecular identification of a danger signal that alerts the immune system to dying cells","volume":"425","author":"Shi","year":"2003","journal-title":"Nature"},{"key":"B93","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1007\/s00223-017-0373-1","article-title":"Bone loss in rheumatoid arthritis: Basic mechanisms and clinical implications","volume":"102","author":"Shim","year":"2018","journal-title":"Calcif. Tissue Int."},{"key":"B94","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1152\/physiol.00061.2014","article-title":"Physiological bone Remodeling: Systemic regulation and growth factor involvement","volume":"31","author":"Siddiqui","year":"2016","journal-title":"Physiol. (Bethesda)"},{"key":"B95","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/nrrheum.2017.155","article-title":"Inflammation in gout: Mechanisms and therapeutic targets","volume":"13","author":"So","year":"2017","journal-title":"Nat. Rev. Rheumatol."},{"key":"B96","doi-asserted-by":"publisher","first-page":"101719","DOI":"10.1016\/j.berh.2021.101719","article-title":"Treatment advances in gout","volume":"35","author":"Stamp","year":"2021","journal-title":"Best. Pract. Res. Clin. Rheumatol."},{"key":"B97","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/art.33370","article-title":"NLRP1 gene polymorphism influences gene transcription and is a risk factor for rheumatoid arthritis in han Chinese","volume":"64","author":"Sui","year":"2012","journal-title":"Arthritis Rheum."},{"key":"B98","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.immuni.2006.02.004","article-title":"Critical role for NALP3\/CIAS1\/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1","volume":"24","author":"Sutterwala","year":"2006","journal-title":"Immunity"},{"key":"B99","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: Molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"B100","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nri2062","article-title":"Osteoimmunology: Shared mechanisms and crosstalk between the immune and bone systems","volume":"7","author":"Takayanagi","year":"2007","journal-title":"Nat. Rev. Immunol."},{"key":"B101","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/ard.2004.020800","article-title":"Efficacy of anakinra in active ankylosing spondylitis: A clinical and magnetic resonance imaging study","volume":"63","author":"Tan","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"B102","doi-asserted-by":"publisher","first-page":"R25","DOI":"10.1186\/ar4159","article-title":"Rilonacept in the treatment of acute gouty arthritis: A randomized, controlled clinical trial using indomethacin as the active comparator","volume":"15","author":"Terkeltaub","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"B103","doi-asserted-by":"publisher","first-page":"6625","DOI":"10.4049\/jimmunol.169.11.6625","article-title":"Differential MHC class II-mediated presentation of rheumatoid arthritis autoantigens by human dendritic cells and macrophages","volume":"169","author":"Tsark","year":"2002","journal-title":"J. Immunol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2147\/TACG.S37325","article-title":"The genetic basis of ankylosing spondylitis: New insights into disease pathogenesis","volume":"7","author":"Tsui","year":"2014","journal-title":"Appl. Clin. Genet."},{"key":"B105","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1002\/eji.201041226","article-title":"The inflammasome drives protective Th1 and Th17 cellular responses in disseminated candidiasis","volume":"41","author":"van de Veerdonk","year":"2011","journal-title":"Eur. J. Immunol."},{"key":"B106","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3389\/fimmu.2013.00167","article-title":"New insights in the Immunobiology of IL-1 family members","volume":"4","author":"van de Veerdonk","year":"2013","journal-title":"Front. Immunol."},{"key":"B107","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/nature13322","article-title":"Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis","volume":"512","author":"Vande Walle","year":"2014","journal-title":"Nature"},{"key":"B108","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1080\/08916934.2020.1836488","article-title":"Icariin alleviates rheumatoid arthritis via regulating miR-223-3p\/NLRP3 signalling axis","volume":"53","author":"Wu","year":"2020","journal-title":"Autoimmunity"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.3899\/jrheum.171290","article-title":"Role of MiR-98 and its Underlying mechanisms in systemic lupus erythematosus","volume":"45","author":"Xie","year":"2018","journal-title":"J. Rheumatol."},{"key":"B110","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1517\/14728222.2013.843669","article-title":"Therapeutic potential of interleukin-17 in inflammation and autoimmune diseases","volume":"18","author":"Yan","year":"2014","journal-title":"Expert Opin. Ther. Targets"},{"key":"B111","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/art.41245","article-title":"Direct binding to NLRP3 pyrin domain as a novel strategy to prevent NLRP3-driven inflammation and gouty arthritis","volume":"72","author":"Yang","year":"","journal-title":"Arthritis Rheumatol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4062\/biomolther.2020.004","article-title":"Repurposing auranofin, an anti-rheumatic Gold compound, to treat Acne Vulgaris by targeting the NLRP3 inflammasome","volume":"28","author":"Yang","year":"","journal-title":"Biomol. Ther."},{"key":"B113","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1093\/rheumatology\/kex499","article-title":"Suppression of NLRP3 inflammasome by oral treatment with sulforaphane alleviates acute gouty inflammation","volume":"57","author":"Yang","year":"2018","journal-title":"Rheumatol. Oxf."},{"key":"B114","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.7150\/thno.47860","article-title":"Tofacitinib restores the balance of \u03b3\u03b4Treg\/\u03b3\u03b4T17 cells in rheumatoid arthritis by inhibiting the NLRP3 inflammasome","volume":"11","author":"Yang","year":"2021","journal-title":"Theranostics"},{"key":"B115","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4196\/kjpp.2018.22.1.1","article-title":"Role of inflammasomes in inflammatory autoimmune rheumatic diseases","volume":"22","author":"Yi","year":"2018","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1084\/jem.20111783","article-title":"A novel pathogenic role of the ER chaperone GRP78\/BiP in rheumatoid arthritis","volume":"209","author":"Yoo","year":"2012","journal-title":"J. Exp. Med."},{"key":"B117","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat. Med."},{"key":"B118","doi-asserted-by":"publisher","first-page":"3807","DOI":"10.1002\/art.30593","article-title":"Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response","volume":"63","author":"Zeng","year":"2011","journal-title":"Arthritis Rheum."},{"key":"B119","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jbiosc.2021.02.007","article-title":"Exosomes from adipose derived mesenchymal stem cells alleviate diabetic osteoporosis in rats through suppressing NLRP3 inflammasome activation in osteoclasts","volume":"131","author":"Zhang","year":"2021","journal-title":"J. Biosci. Bioeng."},{"key":"B120","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s10067-017-3900-6","article-title":"Association of NLRP3 polymorphisms with susceptibility to primary gouty arthritis in a Chinese Han population","volume":"37","author":"Zhang","year":"2018","journal-title":"Clin. Rheumatol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1038\/nrendo.2013.161","article-title":"Clinical implications of shared genetics and pathogenesis in autoimmune diseases","volume":"9","author":"Zhernakova","year":"2013","journal-title":"Nat. Rev. Endocrinol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"714943","DOI":"10.3389\/fimmu.2021.714943","article-title":"Janus kinase inhibition Ameliorates Ischemic Stroke injury and Neuroinflammation through reducing NLRP3 inflammasome activation via JAK2\/STAT3 pathway inhibition","volume":"12","author":"Zhu","year":"2021","journal-title":"Front. Immunol."},{"key":"B123","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41413-019-0057-8","article-title":"Ankylosing spondylitis: Etiology, pathogenesis, and treatments","volume":"7","author":"Zhu","year":"2019","journal-title":"Bone Res."},{"key":"B124","doi-asserted-by":"publisher","first-page":"1559325819901239","DOI":"10.1177\/1559325819901239","article-title":"miR-21 may act as a potential mediator between inflammation and abnormal bone formation in ankylosing spondylitis based on TNF-\u03b1 concentration-dependent manner through the JAK2\/STAT3 pathway","volume":"18","author":"Zou","year":"2020","journal-title":"Dose. Response."}],"container-title":["Frontiers in Molecular Biosciences"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.1027917\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T06:05:36Z","timestamp":1666937136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmolb.2022.1027917\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":124,"alternative-id":["10.3389\/fmolb.2022.1027917"],"URL":"https:\/\/doi.org\/10.3389\/fmolb.2022.1027917","relation":{},"ISSN":["2296-889X"],"issn-type":[{"value":"2296-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,28]]},"article-number":"1027917"}}